MarketsFN
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
Home/Hedge Fund/RTW Investments/Q2 2026

RTW Investments

Periodo: Q2 2026 · Depositato: 2026-08-14
Vedi su SEC EDGAR ↗
AUM
$11.71B
Valore totale del portafoglio
Posizioni
84
Titoli dichiarati
Prima Posizione
MDGL
9.1% $1.07B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2026-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
MDGLMADRIGAL PHARMACEUTICALS INC$1.07B9.14%$536.95$538.71+0.3%
9.1%
ARGXARGENX SE$658.2M5.62%$927.77$1028.51+10.9%
5.6%
PTCTPTC THERAPEUTICS INC$631.9M5.39%$81.57$70.56-13.5%
5.4%
PTGXPROTAGONIST THERAPEUTICS INC$620.4M5.30%$122.58$146.49+19.5%
5.3%
CGONCG ONCOLOGY INC$605.0M5.16%$71.05$75.86+6.8%
5.2%
INSMINSMED INC$516.4M4.41%$106.62$121.51+14.0%
4.4%
TNGXTANGO THERAPEUTICS INC$434.5M3.71%$31.26$22.35-28.5%
3.7%
SYRESPYRE THERAPEUTICS INC$377.5M3.22%$88.78$88.50-0.3%
3.2%
CELCCELCUITY INC$345.8M2.95%$104.62$91.98-12.1%
3.0%
ERASERASCA INC$328.8M2.81%$18.32$16.76-8.5%
2.8%
RDNTRADNET INC$298.9M2.55%$61.67$75.52+22.5%
2.5%
ORKAORUKA THERAPEUTICS INC$298.7M2.55%$95.17$92.11-3.2%
2.5%
NTRANATERA INC$271.4M2.32%$271.45$320.76+18.2%
2.3%
RAREULTRAGENYX PHARMACEUTICAL IN$260.3M2.22%$33.39$25.81-22.7%
2.2%
IRTCIRHYTHM HOLDINGS INC$259.6M2.22%$118.95$122.35+2.9%
2.2%
CYTKCYTOKINETICS INC$243.8M2.08%$85.19$71.40-16.2%
2.1%
KLRAKAILERA THERAPEUTICS INC$237.4M2.03%$22.03$16.41-25.5%
2.0%
ESTAESTABLISHMENT LABS HLDGS INC$227.9M1.95%$85.81$69.55-18.9%
1.9%
GHGUARDANT HEALTH INC$222.2M1.90%$150.03$164.41+9.6%
1.9%
NBIXNEUROCRINE BIOSCIENCES INC$213.7M1.82%$168.54$156.76-7.0%
1.8%
TARSTARSUS PHARMACEUTICALS INC$211.3M1.80%$62.94$74.05+17.6%
1.8%
STOKSTOKE THERAPEUTICS INC$184.0M1.57%$32.72$30.89-5.6%
1.6%
QUREUNIQURE NV$181.6M1.55%$46.06$47.86+3.9%
1.6%
ACADACADIA PHARMACEUTICALS INC$180.8M1.54%$25.30$28.89+14.2%
1.5%
RGENREPLIGEN CORP$169.3M1.45%$136.44$170.02+24.6%
1.4%
URGNUROGEN PHARMA LTD$167.2M1.43%$36.80$43.39+17.9%
1.4%
GHRSGH RESEARCH PLC$159.5M1.36%$26.88$27.36+1.8%
1.4%
IMCRIMMUNOCORE HLDGS PLC$154.6M1.32%$31.75$36.86+16.1%
1.3%
CMPSCOMPASS PATHWAYS PLC$151.4M1.29%$14.15$13.24-6.4%
1.3%
IMTXIMMATICS N.V$131.1M1.12%$10.13$9.43-6.9%
1.1%

Attività Trimestre su Trimestre

Q2 2026 vs. Q1 2026

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
KLRAKAILERA THERAPEUTICS INC$237.4M-25.5%
GPCRSTRUCTURE THERAPEUTICS INC$86.3M
AXGNAXOGEN INC$46.7M
DHRDANAHER CORP DEL$43.8M
SLDBSOLID BIOSCIENCES INC$38.9M
IDYAIDEAYA BIOSCIENCES INC$13.8M
ALLOALLOGENE THERAPEUTICS INC$6.8M
MAZEMAZE THERAPEUTICS INC$6.3M

Posizioni Chiuse (8)

TickerEmittenteNozionale
APGEAPOGEE THERAPEUTICS INC$234.2M
APLSAPELLIS PHARMACEUTICALS INC$148.3M
ISRGINTUITIVE SURGICAL INC$101.4M
CNTACENTESSA PHARMACEUTICALS PLC$81.6M
CRNXCRINETICS PHARMACEUTICALS IN$52.7M
WAYWAYSTAR HLDG CORP$39.3M
ARWRARROWHEAD PHARMACEUTICALS IN$36.7M
SYKSTRYKER CORPORATION$32.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RAREULTRAGENYX PHARMACEUTICAL IN$183.9M+113.7%-22.7%
TENXTENAX THERAPEUTICS INC$4.2M+88.1%
LRMRLARIMAR THERAPEUTICS INC$1.1M+71.1%
ORKAORUKA THERAPEUTICS INC$197.8M+52.5%-3.2%
QUREUNIQURE NV$139.3M+52.4%+3.9%
CGEMCULLINAN THERAPEUTICS INC$18.8M+38.6%
DFTXDEFINIUM THERAPEUTICS INC$13.2M+33.3%
IRTCIRHYTHM HOLDINGS INC$62.7M+30.8%+2.9%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
AVTXAVALO THERAPEUTICS INC$-9.6M-79.6%
HNGEHINGE HEALTH INC$-32.9M-74.1%
COGTCOGENT BIOSCIENCES INC$-120.8M-57.7%
XGNEXAGEN INC$-0.3M-50.7%
HTFLHEARTFLOW INC$-3.4M-40.4%
BBNXBETA BIONICS INC$3.5M-25.0%
NTRANATERA INC$21.5M-20.0%+18.2%
TSHATAYSHA GENE THERAPIES INC$31.2M-0.9%
← Torna agli Hedge Fund